Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical ...

Becton, Dickinson, headquartered in Franklin Lakes, New Jersey, said it plans to invest more than $30 million in 2025 to increase manufacturing of IV lines and boost output of catheter solutions.

Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has ...